Order Article Reprints

DeMarco JK, Royal JM, Severson WE, Gabbard JD, Hume S, Morton J, Swope K, Simpson CA, Shepherd JW, Bratcher B, et al. CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associated Immunopathology. Vaccines. 2021; 9(11):1346. https://doi.org/10.3390/vaccines9111346

DeMarco, Jennifer K., Joshua M. Royal, William E. Severson, Jon D. Gabbard, Steve Hume, Josh Morton, Kelsi Swope, Carrie A. Simpson, John W. Shepherd, Barry Bratcher, and et al. 2021. "CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associated Immunopathology" Vaccines 9, no. 11: 1346. https://doi.org/10.3390/vaccines9111346

DeMarco, J. K., Royal, J. M., Severson, W. E., Gabbard, J. D., Hume, S., Morton, J., Swope, K., Simpson, C. A., Shepherd, J. W., Bratcher, B., Palmer, K. E., & Pogue, G. P. (2021). CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associated Immunopathology. Vaccines, 9(11), 1346. https://doi.org/10.3390/vaccines9111346